{"url_path":"/sec/crvs/8-k/2026-07-22/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1626971/0001104659-26-085790-index.html","accession_number":"0001104659-26-085790","cik":"0001626971","ticker":"CRVS","issuer_name":"Corvus Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1626971/0001104659-26-085790-index.html","primary_entity_key":"0001626971","primary_entity_name":"Corvus Pharmaceuticals, Inc."},"word_count":144,"has_tables":true,"body_markdown":"**Item 5.02.**\n\n**Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\nOn July 21, 2026, Ian T. Clark delivered notice of his intention to resign from the board of directors (the “Board”) of Corvus Pharmaceuticals, Inc. (the “Company”), effective as of July 22, 2026.\n\nThe Company thanks Mr. Clark for his significant contributions to the Company during over nine years of Board service.\n\n​\n\n​\n\n​\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n​\n\n​\n\n**  ​ ​ ​ ​**\n\n**CORVUS PHARMACEUTICALS, INC.**\n\n​\n\n​\n\n​\n\nDate: July 22, 2026\n\n​\n\nBy:\n\n/s/ Leiv Lea\n\n​\n\n​\n\n​\n\nLeiv Lea\n\n​\n\n​\n\n​\n\nChief Financial Officer\n\n​\n\n​\n\n​\n\n​"}